Synovial chondromatosis is a benign neoplastic process where metaplastic chondrocyte proliferation of the synovial membrane produces multiple intraarticular cartilaginous loose bodies. Primary (idiopathic — de novo metaplasia of synovial membrane) and secondary (osteoarthritis, osteochondral fracture, post-traumatic — synovial inclusion of intraarticular loose bodies) forms exist. Knee is the most commonly affected joint (50-65%), followed by hip, elbow, and shoulder — typically monoarticular involvement. On CT, multiple calcified intraarticular loose bodies with ring-and-arc calcification pattern is pathognomonic — direct radiologic reflection of endochondral ossification. On MRI, non-calcified cartilaginous bodies are T2 hyperintense, calcified ones show low T1/T2 signal. Rare risk of malignant transformation (synovial chondrosarcoma — 1-5%) exists and histopathologic evaluation is critical in recurrent or long-standing cases.
Age Range
25-55
Peak Age
40
Gender
Male predominant
Prevalence
Rare
In primary synovial chondromatosis, metaplastic cartilage nodules form in the subintimal layer of the synovial membrane — synovial fibroblasts transform into chondrocytes (metaplasia). The process progresses through three stages (Milgram staging): Stage 1 — active cartilage formation within synovium (intrasynovial chondral metaplasia) but loose bodies have not yet fallen into joint space, only synovial thickening and nodularity are seen; Stage 2 — cartilage nodules detach from synovium into joint space (loose bodies form) and synovial activity continues — most commonly diagnosed stage with both synovial thickening and loose bodies; Stage 3 — synovial activity ceases, only loose bodies remain in joint, synovial thickening is minimal or absent. Calcification of loose bodies occurs through endochondral ossification process — cartilage core forms first (hyaline cartilage matrix — proteoglycan + type II collagen + water), then calcification begins periphery to center (calcium hydroxyapatite crystals precipitate into cartilage matrix) → ring-and-arc pattern develops. CT ring-and-arc calcification is the direct imaging correlate of this endochondral ossification and is specific to cartilaginous neoplasms (chondromatosis, chondrosarcoma, enchondroma). On MRI, non-calcified cartilaginous bodies appear T2 hyperintense like hyaline cartilage — cartilage matrix contains 65-80% water and free water protons have long T2 relaxation time. Calcified bodies show low signal — calcium has low proton density and ultra-short T2 producing no signal on conventional MR sequences. Malignant transformation risk increases with long-standing disease, recurrences, rapid growth, and atypical synovial thickening pattern.
Intraarticular loose bodies showing peripheral ring-shaped calcification + central low-attenuation cartilage matrix on CT is the radiologic reflection of endochondral ossification and pathognomonic for cartilaginous neoplasm. This pattern may be seen in primary synovial chondromatosis, enchondroma, and low-grade chondrosarcoma — but in the context of multiple intraarticular bodies, strongly suggests synovial chondromatosis.
CT shows numerous calcified loose bodies within the joint — bodies typically show 'ring-and-arc' calcification pattern: peripheral ring-shaped calcification (outer shell of endochondral ossification) + central low-attenuation cartilage matrix (not yet calcified hyaline cartilage core). Bodies are similar in size (few mm - 2 cm) and this homogeneous size distribution is typical for primary chondromatosis — in secondary form, bodies are of varying sizes. Bodies are distributed in joint space, synovial recesses, and bursal extensions. Some bodies may be completely calcified (homogeneous high attenuation) — advanced endochondral ossification. This finding is specific to cartilaginous neoplasms and pathognomonic.
Report Sentence
Multiple calcified loose bodies with ring-and-arc calcification pattern are seen in the joint on CT, pathognomonic for synovial chondromatosis.
On T2 fat-sat images, non-calcified cartilaginous loose bodies appear as hyperintense nodules — bright appearance due to high water content like hyaline cartilage. Calcified bodies show low T2 signal (calcium — short T2, low proton density). Mixed calcified/non-calcified bodies show heterogeneous signal — partly bright partly dark. Accompanying synovial thickening shows intermediate T2 signal and joint effusion is prominent as hyperintense fluid. Loose bodies within effusion may appear as 'floating' nodules — non-calcified bodies may show signal similar to effusion fluid, and in such cases contrast images (synovial enhancement, bodies do not enhance) are distinguishing. On gradient-echo (GRE/T2*) sequences, calcified bodies may show susceptibility 'blooming' — but unlike PVNS hemosiderin blooming, calcified bodies are distributed as discrete multiple nodules.
Report Sentence
Multiple intraarticular loose bodies with T2 hyperintense and low signal components are seen on MRI, consistent with synovial chondromatosis.
On post-contrast T1 fat-sat, synovial membrane thickening and enhancement are seen — reflecting active synovial cartilage formation (Milgram Stage 1-2). Synovial thickening may be nodular (metaplastic cartilage nodules) or diffuse. Enhancement indicates synovial neovascularization — indicating active synovial process continuation. In Stage 3, synovial activity has ceased so enhancement is minimal or absent. Loose bodies do not enhance — avascular structures. The difference between synovial enhancement and non-enhancement of loose bodies has diagnostic value and aids differentiation of non-calcified bodies (may be isointense with effusion) within effusion.
Report Sentence
Synovial membrane thickening and enhancement are noted on post-contrast images, consistent with active synovial process (Milgram Stage 1-2).
On B-mode US, multiple hyperechoic/echogenic nodular structures are seen within intraarticular fluid (effusion) — calcified loose bodies. Calcified bodies show strong posterior acoustic shadow — tissues behind remain dark due to calcium absorbing sound waves. Non-calcified cartilaginous bodies may appear hypoechoic or isoechoic and may be difficult to differentiate within effusion. Synovial thickening appears as hypoechoic or heterogeneous structure around bursa/joint capsule. US dynamic assessment can show loose bodies displacing with movement (like beads falling) — confirming bodies are truly free. Power Doppler can show increased vascularity in active synovial areas — synovial neovascularization.
Report Sentence
Multiple echogenic bodies with posterior acoustic shadow are noted within intraarticular fluid on US, consistent with synovial chondromatosis.
On T1 images, loose bodies show low-intermediate signal. Non-calcified cartilaginous bodies show intermediate signal (cartilage matrix), calcified bodies show low signal (calcium). Characteristic finding of primary chondromatosis is similar size of bodies (size uniformity) — in secondary form (from osteoarthritis), bodies are of varying sizes and morphologies. On T1, fat-containing bodies (bone marrow formation — advanced endochondral ossification) may show high signal. Body count ranges from few to hundreds — 'snowstorm' appearance describes presence of numerous bodies.
Report Sentence
Multiple loose bodies of uniform size with low-intermediate T1 signal are noted, consistent with primary synovial chondromatosis.
Criteria
Active intrasynovial cartilage formation, loose bodies not yet detached into joint space. Synovial thickening and nodularity seen.
Distinct Features
MRI: synovial thickening and nodularity, enhancement. Radiograph/CT may be normal (no calcification). Diagnosis difficult — synovial biopsy may be needed. May be confused with PVNS and inflammatory arthropathy.
Criteria
Active synovial process + intraarticular loose bodies. Most commonly diagnosed stage.
Distinct Features
Classic presentation — both calcified bodies on CT and synovial enhancement on contrast MRI. Treatment: arthroscopic/open synovectomy + loose body removal. Recurrence risk high if synovectomy not performed.
Criteria
Synovial activity ceased, only intraarticular loose bodies. No or minimal synovial thickening.
Distinct Features
No/minimal synovial enhancement. Loose body removal may be sufficient, full synovectomy may not be needed. Lowest recurrence rate.
Distinguishing Feature
PVNS shows pathognomonic hemosiderin T2* GRE 'blooming' artifact and lobulated solid synovial mass with low T1/T2 signal — no calcified loose bodies. Chondromatosis shows pathognomonic calcified loose bodies with ring-and-arc pattern — no hemosiderin blooming. Both show synovial thickening but with different signal characteristics.
Distinguishing Feature
Rheumatoid arthritis shows synovial pannus formation and bone erosions — intraarticular loose bodies and calcification are not typical. Synovial enhancement seen in both but in RA pannus characteristically erodes bone margins. In chondromatosis, bone erosion is usually secondary to mechanical pressure.
Distinguishing Feature
Synovial sarcoma (chondrosarcoma transformation) shows aggressive solid component, rapid growth, periosteal reaction and atypical calcification on CT — in benign chondromatosis bodies are uniform, synovial thickening is controlled, no aggressive growth. Malignant transformation (1-5%) should be investigated in recurrences — rapid growth, increasing size, and atypical synovial thickening are warning findings.
Urgency
routineManagement
surgicalBiopsy
NeededFollow-up
12-monthSynovial chondromatosis treatment is surgical loose body removal + synovectomy, with Milgram staging determining treatment strategy. In Stage 1-2, complete synovectomy + loose body removal is recommended — recurrence rate significantly increases with incomplete synovectomy (15-23% vs complete synovectomy 3-5%). In Stage 3, since synovial activity has ceased, loose body removal alone may be sufficient. Arthroscopic approach is preferred for knee and shoulder — less invasive with faster rehabilitation. Deep anatomy of hip and elbow may require open surgery. Overall recurrence rate is 3-23% and long-term MRI follow-up is recommended (annual). Malignant transformation (synovial chondrosarcoma) is rare (1-5%) but a serious risk — especially in long-standing disease and recurrences: rapid growth, increasing body size, aggressive synovial thickening, and periosteal reaction are warning findings. All surgical material should be sent for histopathologic examination — increased cellularity, mitotic activity, and matrix atypia are findings favoring chondrosarcoma transformation.
Surgical synovectomy and removal of loose bodies is the standard treatment approach. Recurrence rate in primary synovial chondromatosis is 15-25%. Malignant transformation (synovial chondrosarcoma) is rare but possible — increasing size and bone destruction on follow-up should raise suspicion. Treatment of underlying osteoarthritis is important in secondary forms.